Biomonitoring Equivalents for DDT/DDE

Regulatory Toxicology and Pharmacology

Volumn 60, Issue 2, 2011, Pages 172-180

  Kirman, Christopher R ^a   Aylward, Lesa L ^a   Hays, Sean M ^a   Krishnan, Kannan ^b   Nong, Andy ^c  

^a LLP   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HEALTH CANADA   (Canada)

Author keywords

Biomonitoring Equivalents; DDD (1,1 dichloro 2,2 bis(p chloro phenyl)ethane); DDE (1,1 dichloro 2,2 bis(p chlorophenyl)ethane); DDT (1,1,1 trichloro 2,2 bis(p chlorophenyl)ethane; Risk assessment; Toxicokinetics

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; 1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; CHLORPHENOTANE;

ARTICLE; BIOLOGICAL MONITORING; BIOMONITORING EQUIVALENT; BLOOD LEVEL; CANCER RISK; CONCENTRATION (PARAMETERS); DEGRADATION; GOVERNMENT; HALF LIFE TIME; HUMAN; METABOLITE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

ANIMALS; DDT; DICHLORODIPHENYL DICHLOROETHYLENE; DICHLORODIPHENYLDICHLOROETHANE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GUIDELINES AS TOPIC; HALF-LIFE; HUMANS; INSECTICIDES; RISK ASSESSMENT;

EID: 79958254497     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.03.012     Document Type: Article

References (66)

1. ATSDR, 2002. Toxicological profile for DDT, DDE, and DDD. US Department of Health and Human Services: Agency for Toxic Substances and Disease Registry.
2. Aylward L.L., Lakind J.S., Hays S.M. Derivation of biomonitoring equivalent (BE) values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds: a screening tool for interpretation of biomonitoring data in a risk assessment context. J. Toxicol. Environ. Health A 2008, 71(22):1499-1508.
3. Bulger W.H., Kupfer D. Estrogenic action of DDT analogs. Am. J. Ind. Med. 1983, 4(1-2):163-173.
4. Byczkowski J.Z. Biochemical and ultrastructural changes in biological membranes induced by p,p'-DDT (chlorophenotanum) and its metabolites. Pol. J. Pharmacol. Pharm. 1977, 29(4):411-417.
5. Cabral J.R., Hall R.K., Rossi L., Bronczyk S.A., Shubik P. Effects of long-term intake of DDT on rats. Tumori 1982, 68:11-17.
6. CDC, 2009. Fourth National Report on Human Exposure to Environmental Chemicals. Center for Disease Control and Prevention.
7. Chaudhuri R., Sigler K., Dupont E., Trosko J.E., Malkinson A.M., Ruch R.J. Gap junctional intercellular communication in mouse lung epithelial cell lines: effects of cell transformation and tumor promoters. Cancer Lett. 1993, 71(1-3):11-18.
8. Clement J., Okey A. Reproduction in female rats born to DDT-treated parents. Bull. Environ. Contam. Toxicol. 1974, 12(3):373-377.
9. Edmundson W.F., Davies J.E., Cranmer M. DDT and DDE in blood and DDA in urine of men exposed to 3 percent DDT aerosol. Public Health Rep. 1970, 85(5):457-463.
10. Fang S.C., Fallin E., Freed V.H. Maternal transfer of 14C-p, p'-DDT via placenta and milk and its metabolism in infant rats. Arch. Environ. Contam. Toxicol. 1977, 5(4):427-436.
11. Gingell R. Metabolism of [14C]-DDT in the mouse and hamster. Xenobiotica 1976, 6(1):15-20.
12. Gingell R., Wallcave L. Species differences in the acute toxicity and tissue distribution of DDT in mice and hamsters. Toxicol. Appl. Pharmacol. 1974, 28(3):385-394.
13. Gold B., Brunk G. Metabolism of 1,1,1-trichloro-2, 2-bis(p-chlorophenyl)ethane and 1, 1-dichloro-2, 2-bis(p-chlorophenyl)ethane in the mouse. Chem. Biol. Interact. 1982, 41:327-339.
14. Gupta B., Agarwal H.C. Metabolism and distribution of DDT in mouse in relation to poisoning symptoms. Indian J. Exp. Biol. 1974, 12(5):402-405.
15. Haddad S., Poulin P., Krishnan K. Relative lipid content as the sole mechanistic determinant of the adipose tissue:blood partition coefficients of highly lipophilic organic chemicals. Chemosphere 2000, 40(8):839-843.
16. Harada T., Yamaguchi S., Ohtsuka R., Takeda M., Fujisawa H., Yoshida T., Enomoto A., Chiba Y., Fukumori J., Kojima S., Tomiyama N., Saka M., Ozaki M., Maita K. Mechanisms of promotion and progression of preneoplastic lesions in hepatocarcinogenesis by DDT in F344 rats. Toxicol. Pathol. 2003, 31(1):87-98.
17. Hays S.M., Aylward L.L. Using biomonitoring equivalents to interpret human biomonitoring data in a public health risk context. J. Appl. Toxicol. 2009, 29:275-288.
18. Hays S.M., Aylward L.A., Gagne M., Krishnan K. Derivation of biomonitoring equivalents for cyfluthrin. Regul. Toxicol. Pharmacol. 2009, 55(3):268-275.
19. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., Pyatt D.W. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 2007, 47:96-109.
20. Hays S.M., Aylward L.L., LaKind J.S., Bartels M.J., Barton H.A., Boogaard P.J., Brunk C., DiZio S., Dourson M., Goldstein D.A., Lipscomb J., Kilpatrick M.E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.M., Viau C., Yager J.W. Guidelines for the derivation of biomonitoring equivalents: report from the Biomonitoring Equivalents ExpertWorkshop. Regul. Toxicol. Pharmacol. 2008, 51:S4-S15.
21. Hayes W.J., Dale W.E., Pirkle C.I. Evidence of safety of long-term, high, oral doses of DDT for man. Arch. Environ. Health 1971, 22(1):119-135.
22. Health Canada, 2010. Canadian Health Measures Survey.
23. Jansen L.A., Jongen W.M. The use of initiated cells as a test system for the detection of inhibitors of gap junctional intercellular communication. Carcinogenesis 1996, 17(2):333-339.
24. Keller W.C., Yeary R.A. A comparison of the effects of mineral oil, vegetable oil, and sodium sulfate on the intestinal absorption of DDT in rodents. Clin. Toxicol. 1980, 16(2):223-231.
25. Kitagawa T., Hino O., Nomura K., Sugano H. Dose-response studies on promoting and anitcarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Carcinogenesis 1984, 5(12):1653-1656.
26. Kitamura S., Shimizu Y., Shiraga Y., Yoshida M., Sugihara K., Ohta S. Reductive metabolism of p,p'-DDT and o, p'-DDT by rat liver cytochrome P450. Drug Metab. Dispos. 2002, 30(2):113-118.
27. Klaunig J.E., Ruch R.J., Weghorst C.M. Comparative effects of phenobarbital, DDT, and lindane on mouse hepatocyte gap junction intercellular communication. Toxicol. Appl. Pharmacol. 1990, 102(3):553-563.
28. LaKind J.S., Aylward L.L., Brunk C., DiZio S., Dourson M., Goldstein D.A., Kilpatrick M.E., Krewski D., Bartels M.J., Barton H.A., Boogaard P.J., Lipscomb J., Krishnan K., Nordberg M., Okino M., Tan Y.M., Viau C., Yager J.W., Hays S.M. Guidelines for the communication of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop. Regul. Toxicol. Pharmacol. 2008, 51:S16-S26.
29. Laug E.P., Nelson A.A., Fitzhugh O.G., Kunze F.M. Liver cell alternation and DDT storage in the fat of the rat induced by dietary levels of 1 to 50ppm DDT. J. Pharmacol. Exp. Ther. 1950, 98:268.
30. Morgan D.P., Roan C.C. The metabolism of DDT in man. Essays in Toxicology 1973, 39-97. Academic Press, New York, NY. W. Hayes (Ed.).
31. Muhlebach S., Moor M.J., Wyss P.A., Bickel M.H. Kinetics of distribution and elimination of DDE in rats. Xenobiotica 1991, 21(1):111-120.
32. Murono E.P., Derk R.C. The effects of the reported active metabolite of methoxychlor, 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane, on testosterone formation by cultured Leydig cells from young adult rats. Reprod. Toxicol. 2004, 19(1):135-146.
33. NCI, 1978. National Cancer Institute. Bioassays of DDT, TDE, and p,p'-DDE for possible carcinogenicity. CAS No. 50-29-3, 72-54-8, 72-55-9 NCI-CG-TR-131.
34. Noguchi T., Charman W., Stella V. Lymphatic appearance of DDT in thoracic or mesenteric lymph duct cannulated rats. Int. J. Pharm. 1985, 24:185-192.
35. Peraino C., Fry R.J., Staffeldt E., Christopher J.P. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-aminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 1975, 35(10):2884-2890.
36. Phillips D.L., Pirkle J.L., Burse V.W., Bernert J.T., Henderson L.O., Needham L.L. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch. Environ. Contam. Toxicol. 1989, 18:495-500.
37. Pocock D.E., Vost A. DDT absorption and chylomicron transport in rat. Lipids 1974, 9(6):374-381.
38. Ritter R., Scheringer M., MacLeod M., Schenker U., Hungerbühler K. A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: application to a postban situation. Environ. Health Perspect. 2009, 117(8):1280-1286.
39. RIVM Re-evaluation of human-toxicological maximum permissible risk levels. RIVM report no. 711701025 2001, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, pp. 249-257.
40. RIVM, 2001b. Re-evaluation of human-toxicological maximum permissible risk levels. In: Baars, A.J., Theelen, R.M.C., Janssen, P.J.C.M., Hesse, J.M., Apeldoorn, M.E., van Meijerink, M.C.M., Verdam L, Zeilmaker MJ. Netherlands National Institute for Public Health and the Environment.
41. Rossi L., Ravera M., Repetti G., Santi L. Long-term administration of DDT or phenobarbital-Na in Wistar rats. Int. J. Cancer 1977, 19:179-185.
42. Rossi L., Barbieri O., Sanguineti M., Cabral J.R., Bruzzi P., Santi L. Carcinogenicity study with technical-grade dichlorodiphenyltrichloroethane and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene in hamsters. Cancer Res. 1983, 43:776-781.
43. Rothe C.F., Mattson A.M., Nueslein R.M., Hayes W.J. Metabolism of cholorophenothane (DDT); intestinal lymphatic absorption. AMA Arch. Ind. Health 1957, 16(1):82-86.
44. Ruch R.J., Klaunig J.E. Effects of tumor promoters, genotoxic carcinogens and hepatocytotoxins on mouse hepatocyte intercellular communication. Cell Biol. Toxicol. 1986, 2(4):469-483.
45. Sexton K., Needham L.L., Pirkle J.L. Human biomonitoring of environmental chemicals: Measuring chemicals in human tissues is the " gold standard" for assessing peoples exposures to pollution. Am. Sci. 2004, 92:38-45.
46. Sieber S. The lymphatic absorption of p, p'-DDT and some structurally-related compounds in the rat. Pharmacology 1976, 14:443-454.
47. Smith D. Worldwide trends in DDT levels in human breastmilk. Int. J. Epidemiol. 1999, 28(2):179-188.
48. Smith A.G. How toxic is DDT?. Lancet 2000, 356:267-268.
49. Sugie S., Mori H., Takahashi M. Effect of in vivo exposure to the liver tumor promoters phenobarbital or DDT on the gap junctions of rat hepatocytes: a quantitative freeze-fracture analysis. Carcinogenesis 1987, 8(1):45-51.
50. Terracini B., Testa M., Cabral J., Day N. The effects of long-term feeding of DDT to balb/c mice. Int. J. Cancer 1973, 11:747-764.
51. Thorpe E., Walker A.I. The toxicology of dieldrin. II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and alpha-BHC. Food Cosmet. Toxicol. 1973, 11:433-442.
52. Tomatis L., Turusov V. Studies in the carcinogenicity of DDT. Gann 1975, 17:219-241.
53. Tomatis L., Turusov V., Day B., Barthel W., Collins G., Boiocchi M. Storage levels of DDT metabolites in mouse tissues following longterm exposure to technical DDT. Tumori 1971, 57:377-396.
54. Tomatis L., Turusov V., Charles R.T., Boiocchi M., Gati E. Effect of long-term exposure to 1,1-dichloro-2,2-bis(p-chlorphenyl)ethylene, to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethane and to the two chemicals combined on CF-1 mice. J. Natl. Cancer Inst. 1974, 52(3):883-891.
55. Tomatis L., Turusov V., Charles R.T., Boiocchi M., Gati E. Liver tumours in CF-1 mice exposed for limited periods to technical DDT. Cancer Res. Clin. Oncol. 1974, 82:25-35.
56. Turner J., Shanks V. Absorption of some organochlorine compounds by the rat small intestine in vivo. Bull. Environ. Contam. Toxicol. 1980, 24:652-655.
57. Turusov V.S., Day N.E., Tomatis L., Gati E., Charles R.T. Tumors in CF-1 mice exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 1973, 51(3):983-997.
58. USEPA, 1988. Integrated risk information system (IRIS). DDE. Cancer assessment. Available at: http://www.epa.gov/NCEA/iris/subst/0328.htm.
59. USEPA, 1991. Integrated risk information system (IRIS). DDT. Cancer assessment. Available at: http://www.epa.gov/NCEA/iris/subst/0147.htm.
60. USEPA, 1996. Integrated risk information system (IRIS). DDT. Noncancer assessment. Available at: http://www.epa.gov/NCEA/iris/subst/0147.htm.
61. Verner M.A., Ayotte P., Muckle G., Charbonneau M., Haddad S. A physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies. Environ. Health Perspect. 2009, 117(3):481-487.
62. WHO, 2000. Evaluation of the toxicity of pesticide residues in food. World Health Organization. FAO Meeting Report No. PL/1965/10/1.
63. Wolff M.S., Zeleniuch-Jacquotte A., Dubin N., Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol. Biomarkers Prev. 2000, 9:271-277.
64. Woolley D.E., Talens G.M. Distribution of DDT, DDD, and DDE in tissues of neonatal rats and in milk and other tissues of mother rats chronically exposed to DDT. Toxicol. Appl. Pharmacol. 1971, 18:907-916.
65. You L., Gazi E., Archibeque-Engle S., Casanova M., Connolly R.M., Heck H.A. Transplacental and lactational transfer of p,p'-DDE in Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 1999, 157:134-144.
66. You L., Sar M., Bartolucci E., Ploch S., Whitt M. Induction of hepatic aromatase by p,p'-DDE in adult male rats. Mol. Cell. Endocrinol. 2001, 178(1-2):207-214.